![Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2 | Scientific Reports Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2 | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-80896-9/MediaObjects/41598_2020_80896_Fig1_HTML.png)
Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2 | Scientific Reports
Convergent antibody evolution and clonotype expansion following influenza virus vaccination | PLOS ONE
Convergent antibody evolution and clonotype expansion following influenza virus vaccination | PLOS ONE
![COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1619703711/GettyImages-1293456793.jpg/GettyImages-1293456793.jpg?VersionId=WB8tj9FiBVgpCnJxtaqj0TT3Gnf4tWIM)
COVID-19 tracker: Omicron variant could cause global surge, WHO says; J&J recipients opt for other boosters | Fierce Pharma
![Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abd3601/asset/0ff31016-f7d3-42d5-af3a-9a0cdcff693c/assets/graphic/abd3601-f6.jpeg)
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine
![Vaccines | Free Full-Text | Influenza–Host Interplay and Strategies for Universal Vaccine Development | HTML Vaccines | Free Full-Text | Influenza–Host Interplay and Strategies for Universal Vaccine Development | HTML](https://www.mdpi.com/vaccines/vaccines-08-00548/article_deploy/html/images/vaccines-08-00548-g004.png)
Vaccines | Free Full-Text | Influenza–Host Interplay and Strategies for Universal Vaccine Development | HTML
![A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination | Nature Medicine A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-021-01636-8/MediaObjects/41591_2021_1636_Fig1_HTML.png)
A single residue in influenza virus H2 hemagglutinin enhances the breadth of the B cell response elicited by H2 vaccination | Nature Medicine
![Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721012250-fx1.jpg)
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
![Mitigation of biases in estimating hazard ratios under non-sensitive and non-specific observation of outcomes–applications to influenza vaccine effectiveness | Emerging Themes in Epidemiology | Full Text Mitigation of biases in estimating hazard ratios under non-sensitive and non-specific observation of outcomes–applications to influenza vaccine effectiveness | Emerging Themes in Epidemiology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12982-020-00091-z/MediaObjects/12982_2020_91_Fig2_HTML.png)
Mitigation of biases in estimating hazard ratios under non-sensitive and non-specific observation of outcomes–applications to influenza vaccine effectiveness | Emerging Themes in Epidemiology | Full Text
![Cureus | A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination Cureus | A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination](https://assets.cureus.com/uploads/figure/file/211206/9fdf3b00a67a11ebaee9e55e76c34e20-Figure1.png)
Cureus | A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination
![Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abd3601/asset/ccb24016-1508-4dbc-8f0f-35a5211afa8a/assets/graphic/abd3601-f2.jpeg)
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine
![Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abd3601/asset/2018990e-4178-451b-a4c2-096d220442fc/assets/graphic/abd3601-f1.jpeg)
Preexisting immunity shapes distinct antibody landscapes after influenza virus infection and vaccination in humans | Science Translational Medicine
![Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study | Journal of Virology Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study | Journal of Virology](https://journals.asm.org/cms/10.1128/JVI.01150-19/asset/0877ad58-597c-4d17-8659-b79667340d4f/assets/graphic/jvi.01150-19-f0005.jpeg)
Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study | Journal of Virology
![Vaccines | Free Full-Text | Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development | HTML Vaccines | Free Full-Text | Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development | HTML](https://www.mdpi.com/vaccines/vaccines-09-01052/article_deploy/html/images/vaccines-09-01052-g001.png)
Vaccines | Free Full-Text | Shooting at a Moving Target—Effectiveness and Emerging Challenges for SARS-CoV-2 Vaccine Development | HTML
![Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes | PNAS Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes | PNAS](https://www.pnas.org/cms/10.1073/pnas.2018102118/asset/e93f658e-b851-4ba3-ad1e-bb484a907404/assets/images/large/pnas.2018102118fig01.jpg)
Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes | PNAS
![Rational Development of a Polysaccharide–Protein‐Conjugated Nanoparticle Vaccine Against SARS‐CoV‐2 Variants and Streptococcus pneumoniae - Deng - 2022 - Advanced Materials - Wiley Online Library Rational Development of a Polysaccharide–Protein‐Conjugated Nanoparticle Vaccine Against SARS‐CoV‐2 Variants and Streptococcus pneumoniae - Deng - 2022 - Advanced Materials - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5c408ae9-30d2-4c36-a2cc-d3fb78abac66/adma202200443-fig-0005-m.jpg)